Business Express is an online portal that covers the latest developments in the world of business and finance. From startups and entrepreneurship to mergers and acquisitions, Business Express provides reporting on the stories that matter most to business leaders and decision-makers.The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Research Report 1 1 1 - Business Express

Non-Surgical Fat Reduction Market is expected to reach US$ 4.5 Billion by the end of 2032 | FMI

The fat in the target area is frozen and destroyed during the non-invasive treatment known as cryolipolysis. The body’s metabolic pathways then eliminate the fat over the course of two to six months. For instance, according to a survey by the American Society of Plastic Surgeons, this is one of the most widely used nonsurgical fat reduction treatments with over 450,000 surgeries performed worldwide.

The global non-surgical fat reduction market is anticipated to reach a value of US$ 1.3 billion by the end of 2022 and to grow at a CAGR of 13.6% to US$ 4.5 billion by 2032. Cryolipolysis will hold the top spot in the global market in 2021 with a share of roughly 33.3%, according to a recent analysis by Future Market Insights.

The report on the non-surgical fat reduction market further projects significant growth potential with average year-on-year growth rate of 5.1% through 2022. Non-surgical fat reduction is a minimally invasive treatment of body fat reduction. Non-surgical fat reduction is conducted through various technologies including heat, cooling, medication and injectable.

Non-surgical fat reduction is performed with variety of devices, including radio frequency, infrared light, ultrasound, and injectable medication.

Request for a sample @

Obesity leads to serious health problems including heart disease, high blood pressure, diabetes, and cancers in certain cases. Excess deposition of body fat triggers insulin production, which lead to diabetes.

According to a study conducted by Harvard, the risk of diabetes is 20 times more in obese population. This also increases the risk of high blood pressure, gallstones and stroke.

The growing number of obese population is seeking for cost-effective, less painful non-surgical fat reduction procedures, which can be performed at outpatient centres or beauty clinics. Some of the most popular procedures among non-surgical fat reduction are injection lipolysis, cryolipolysis, laser lipolysis, and radiofrequency lipolysis.

The non-surgical fat reduction market is predominated by few companies that are offering their approved products to the end users.

These companies are competing in the non-surgical fat reduction market through product differentiation strategy.

The leading players operating in the market have varied range of products, which operate on different technologies. Non-surgical fat reduction is gaining popularity among teen-age groups.

According to the American Society of Plastic Surgeons (ASPS), approximately 229,000 cosmetic procedures were conducted on teen-aged patients (age 13 to 19) in 2017.

The prime reason behind the increased number of plastic surgeries among teen-age group is social media-obsessed culture, where teenagers opt for various type of plastic surgery.

The increasing number of teen-age population across beauty clinics is likely to boost the growth of Non-surgical fat reduction market.

Non-surgical fat reduction is gaining popularity among women who have undergone C-section during their pregnancy.

This patient population is seeking for body-contouring treatments for their post-pregnancy marks. Non-surgical fat reduction is a cost-effective solution for body-contouring women.

Request Report Methodology @

Non-surgical fat reduction techniques available in the market are also targeting population that are looking for temporary fat reduction solution.

In order to cater the demand, Syneron Medical Ltd (UltraShape) & Valeant Pharmaceuticals International, Inc. (Liposonix) are offering FDA approved products for ultrasound fat reduction treatment.

The devices offered by the companies use focused ultrasonic waves to break the fat while leaving surrounding tissues unharmed.

Non-surgical fat reduction with laser-based technology is adopted by patient looking for fat reduction in particular areas such as hips, waist and thighs.

Most of the surgeons does not recommend laser-based surgery for pregnant mothers, or women trying to conceive or for people with pacemakers.

Based on the product type, the laser-based devices segment is expected to account a high share in the global non-surgical fat reduction market in terms of value throughout the forecast period.

Moreover, this segment is projected to register a CAGR of 5.6% through 2022.

FMI has segmented the global non-surgical fat reduction market based on product type, end users, & regions.

In terms of revenue, the beauty clinics end-user segment holds substantial share in the non-surgical fat reduction market and is expected to gain momentum over the forecast period due to increasing awareness regarding cost-effective non-surgical fat reduction procedures.

Examples of some of the companies profiled in the report are Cutera Inc., Syneron Medical Ltd., Lutronic Corporation, Fotona d.d., Cynosure, Inc., Solta Medical Inc., Lynton Lasers Ltd., Alma Lasers, Ltd., Venus Concept Canada Corp., EL.En. S.p.A., and Sciton, Inc.

Ask from Market Research Expert @

Don't miss out on any breaking news or insightful opinions!
Subscribe to our free newsletter and stay updated on the go!

By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.


Based on product type, the non-surgical fat reduction market is segmented into

  • radiofrequency devices
  • laser based devices
  • ultrasound devices
  • other.

The end-use segments covered are

  • dermatology clinics
  • beauty clinics.

The non-surgical fat reduction market has been analysed across regions of

  • North America
  • Eastern Europe
  • Western Europe
  • Latin America
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa

Full Report @

Table of Content

  1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply-Side Trends

1.4. Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

Explore FMI’s Extensive Coverage On Healthcare Domain:

Virology Specimen Collection Market Demand : The market for virology specimen collection was valued at US$ 5.6 billion globally in 2021, and it is anticipated to grow at a negative CAGR of -0.5% from 2022 to 2032.

In Vitro Fertilization Market Size : The size of the global in vitro fertilisation (IVF) market is anticipated to reach approximately US$ 1.6 Billion by 2032, expanding at a robust CAGR of 9.0% between 2022 and 2032.

Epilepsy Monitoring Devices Market Growth : Throughout the projection period, it is anticipated that the global market for epilepsy monitoring devices will expand at a 5% CAGR and reach US$ 615 Mn by 2026.

Patient Engagement Platforms Market Share : The market for patient engagement platforms is projected to expand at a 17% CAGR over the course of the forecast period, rising from US$ 16.6 billion in 2021 to over US$ 93.4 billion by 2032.

Healthcare Business Intelligence Market analysis : Between 2022 and 2032, the global market for healthcare business intelligence is anticipated to expand at a moderate CAGR of 8.1%. Healthcare business intelligence is anticipated to reach a market value of US$ 3.4 billion in 2022 and US$ 7.4 billion in 2032.

About Future Market Insights, Inc : 

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:

Recent Post: